Completed PHASE4 INTERVENTIONAL 3-arm NCT01091714

Is Omega-3 Fatty Acid Red Blood Cell (RBC) Saturation Product Dependent?

Is Omega-3 Fatty Acid RBC Saturation Product Dependent?

Sponsor: Bucci Laser Vision Institute

Interventions Omega-3

Updated 5 times since 2017 Last updated: Oct 4, 2011 Started: Oct 31, 2010 Primary completion: Jul 31, 2011 Completion: Jul 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01091714, this PHASE4 trial focuses on Cardioprotective Levels and remains completed. Sponsored by Bucci Laser Vision Institute, it has been updated 5 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bucci Laser Vision Institute

Data source: Bucci Laser Vision Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Wilkes-Barre, United States